Monday, December 2, 2019

Affect and vaccination response


This study made a very interesting claim on a critical topic in healthcare. Besides the known fact that vaccinations should not be given to anyone experiencing a fever, I never thought of patient behaviors and psychological well-being as having an influence on vaccination effectiveness. Furthermore, I was surprised to learn that affect can be a significant predictor of H1N1 seroprotection and IgG responses post-vaccination. Although I believe that mood shapes immunological responses, this study does not show a clear, direct correlation between affect and vaccination responses. These beneficial effects of positive affect were not found for the H3N2 and B strains of the vaccination. Future experiments should further investigate the findings made in this study.  
One indirect biological explanation for this relationship is that people with positive moods generally live healthier lifestyles which is associated with a stronger immune system. The paper also touched on prior research linking positive affective states to CNS parasympathetic activation, cortisol secretions, as well as other mechanisms linked to the endocrine system, which as we learned interplays with the immune system. 
I thought that the general outline of the experiment was strong due to being a prospective, diary-based longitudinal study, although I still have some questions with how this experiment was conducted. The study was performed from August 2014 to March 2015, which although is prime flu season, also coincides with many other illnesses. It’s possible that other illnesses or upregulation of the immune system had an effect on the H1N1 seroprotection levels. It’s also possible that people who suffered a cold or any other illness during this time may have experienced less positive mood, therefore causing these decreased IgG levels in those with more negative mood on vaccination day. Furthermore, they excluded participants with cognitive disorders, although I think it would have been interesting to see if there is any correlation between the vaccine-induced protective antibody response and affect, as well as anxiety or fear. It would have been useful to include exactly what kind of cognitive disorders were excluded. 
Another interesting aspect of the study was that the vaccine strain they used for testing was identical to that of the previous year, meaning that many participants had already received the vaccine in the past. In fact, they mentioned that a substantial proportion of participants reached seroprotection thresholds for the H3N2 (63.1%) and B (47.2%) strains of the vaccine at baseline and I wonder whether this prior elevation in protective antibodies affected the results of this study. Finally, although this study has clinical relevance, it would be difficult to implement the findings into a real-life setting. Changing the affect of a person in order to increase the effectiveness of a vaccination would be difficult, especially in those suffering from depression or other cognitive dysfunctions.



No comments:

Post a Comment

Note: Only a member of this blog may post a comment.